NewsBenzinga그린플레인즈 2026년 2분기 실적 발표 컨퍼런스 콜 그린플레인즈 2026년 2분기 실적 발표 컨퍼런스 콜 Benzinga 2026.10.07 11:07 (GMT+0) Open on Benzinga Other news Barclays Maintains Underweight on Allstate, Lowers Price Target to $221 Barclays Maintains Overweight on Agilent Technologies, Raises Price Target to $195 Barclays Maintains Underweight on Aflac, Raises Price Target to $101 StoneX Maintains Buy on Imax, Raises Price Target to $65 Barclays Maintains Overweight on 10x Genomics, Raises Price Target to $110 Barclays Initiates Coverage On Zimmer Biomet Holdings with Equal-Weight Rating, Announces Price Target of $100
Barclays Initiates Coverage On Zimmer Biomet Holdings with Equal-Weight Rating, Announces Price Target of $100
